Skip to main content
SpringerLink
Log in

Pseudoprolongation of the Prothrombin Time During Treatment with Recombinant Factor VIIa for Bleeding in a Patient with a Spontaneous Factor VIII Inhibitor

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa; a multicentre study.Thromb Haemost. 1997;78:1436–1437.

    Google Scholar 

  2. Shirahata A, Kamiya T, Takamatsu J, et al. Clinical trial to investigate the pharmacokinetics, pharmacodynamics, safety, and efficacy of recombinant factor VIIa in Japanese patients with hemophilia with inhibitors.Int J Hematol. 2001;73:517–525.

    Article  PubMed  CAS  Google Scholar 

  3. Macik BG, Lindley CM, Lusher J, et al. Safety and initial efficacy of three dose levels of recombinant activated factor VII (rVIIa): results of a phase I study.Blood Coagul Fibrinolysis. 1993;4:521–5277.

    Article  PubMed  CAS  Google Scholar 

  4. Carr ME, Martin EJ, Carr SL. Delayed, reduced and inhibited thrombin production reduces platelet contractile force and results in weaker clot formation.Blood Coagul Fibrinolysis. 2002;13:193–1977.

    Article  PubMed  CAS  Google Scholar 

  5. Friederich PW, Levi M, Bauer KA, et al. Ability of recombinant factor VIIa to generate thrombin during inhibition of tissue factor in human subjects.Circulation. 2001;103:2555–2559.

    Article  PubMed  CAS  Google Scholar 

  6. Smith LG, Kitchens CS. Pseudo-prolongation of the partial thromboplastin time.Am J Clin Pathol. 1983;80:750–752.

    Article  PubMed  CAS  Google Scholar 

  7. Konle BA. Clinical use and laboratory monitoring of recombinant factor VIIa (NovoSeven“). Presented at: Hemostasis and Thrombosis Update 2001; April 26-28, 2001; Temple University School of Medicine, Philadelphia, Pa.

    Google Scholar 

  8. Cooper HA, Jones CP, Campion E, Roberts HR, Hedner U. Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures.Haemophilia. 2001;7:517–522.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of aPathology, Richmond, Virginia, USA

    Marcus E. Carr, Erika J. Martin, Ann R. Tidwell & Maura K. Hagane

  2. Internal Medicine, Richmond, Virginia, USA

    Marcus E. Carr

  3. Central Virginia Center for Coagulation Disorders, Richmond, Virginia, USA

    Marcus E. Carr & Jan G. Kuhn

  4. Virginia Commonwealth University, Richmond, Virginia, USA

    Marcus E. Carr, Jan G. Kuhn, Erika J. Martin & Ann R. Tidwell

  5. Virginia Cancer Institute, Richmond, Virginia, USA

    Maura K. Hagane

  6. Box 980230, 23298-0230, Richmond, Virginia, USA

    Marcus E. Carr

Authors
  1. Marcus E. Carr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jan G. Kuhn
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erika J. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ann R. Tidwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maura K. Hagane
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcus E. Carr.

About this article

Cite this article

Carr, M.E., Kuhn, J.G., Martin, E.J. et al. Pseudoprolongation of the Prothrombin Time During Treatment with Recombinant Factor VIIa for Bleeding in a Patient with a Spontaneous Factor VIII Inhibitor. Int J Hematol 77, 308–309 (2003). https://doi.org/10.1007/BF02983792

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02983792

Keywords

Search

Navigation